Diversity Alliance for Science Hosts Networking Conference and Expo
Diversity Alliance for Science will hold its Fourth Annual Networking Conference and Expo on May 17?18, 2011 in Newark, New Jersey.
Diversity Alliance for Science will hold its Fourth Annual Networking Conference and Expo on May 17–18, 2011, in Newark, New Jersey. The two-day event will showcase senior government officials, pharmaceutical executives, and CEOs of scientific and clinical businesses, and feature personal networking, relationship building, and collaboration opportunities.
Diversity Alliance for Science supports, mentors, and develops minority-, women-, disabled-, small disadvantaged-, HUBZone-, veteran/service-disabled-, and LGBT-owned businesses in the life science industry. It also works to build relationships between these businesses and government agencies, pharmaceutical firms, biotech companies, and academic medical centers. The primary focus of Diversity Alliance for Science is to identify, develop, and increase spending with diverse suppliers in the life science industry.
This year’s Conference is supported by GlaxoSmithKline, Merck, Amgen, Pfizer, ExecuPharm, Fisher Scientific, Guard Dog Brand Development, Henry Schein, Inc., Johnson & Johnson, Sanofi-aventis, Novartis, Eli Lilly and Company, Abbott, Genentech, VWR International, Daiichi-Sankyo, The Takeda Oncology Company, ISM Pharmaceutical Forum, Bogier Clinical & IT Solutions, Inc., A10 Clinical Solutions, Inc., Liberty IRB, Inc., Bright Pharmaceutical Services, Research Assist, Inc., Integrated Resources, Inc., US Tech Solutions, Drug Safety Alliance, Inc., Caligor Rx, Ancillare Global Clinical Strategies, Spectraforce, and East Hill Video.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
